author-photo

Daniel Molin

Uppsala University

83

Papers

2331

Citations

Citation Trend

Filter By

Papers (62) Sort By

Journal Conference Others

Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (2)
Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders.

2021 Acta Oncologica
Show All
- Source
- Cite
- Save
Citations (0)
Prognostic impact of soluble CD163 in patients with diffuse large Bcell lymphoma.

2021 Haematologica
Show All
- Source
- Cite
- Save
Citations (0)
Real‐world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000–2014, focusing on patients aged >60 years

2021
Show All
- Source
- Cite
- Save
Citations (0)
High risk of cardiovascular side effects after treatment of Hodgkin’s lymphoma – is there a need for intervention in long-term survivors?

2021 Upsala Journal of Medical Sciences
Show All
- Source
- Cite
- Save
Citations (0)
Five-Year Follow-up of Keynote-087: Pembrolizumab Monotherapy in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma

2021 Upsala Journal of Medical Sciences
Show All
- Source
- Cite
- Save
Citations (0)
Pembrolizumab in relapsed or refractory Richter syndrome.

2020 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (8)
Plasma proteome profiling of cardiotoxicity in patients with Diffuse Large B-Cell Lymphoma

2020
Show All
- Source
- Cite
- Save
Citations (0)
Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real‐world patients

2020 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (8)